Keyphrases
Head-and-neck Cancer
100%
Prognostic Biomarker
100%
Targeted Therapy
100%
CHRNB4
100%
Integrated Genomics
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
80%
Smokers
40%
Prognostic Indicator
40%
Angiogenesis
20%
Worse Outcome
20%
Therapeutic Agents
20%
New Therapeutics
20%
Cell Death
20%
Therapeutic Target
20%
Migration Invasion
20%
Distant Metastasis
20%
Survival Analysis
20%
Hazard Ratio
20%
Gene Signature
20%
Increased Incidence
20%
Genetic Modification
20%
RNA Sequencing (RNA-seq)
20%
Inhibition Assay
20%
Pharmaceutical Targets
20%
Former Smokers
20%
Non-smokers
20%
Functional Enrichment
20%
Cancer Cell Migration
20%
Copy number Variation
20%
Co-regulated Genes
20%
Gene Editing
20%
Prognostic Genes
20%
Varenicline
20%
Prevent Recurrence
20%
Alteration Analysis
20%
Drug Inhibition
20%
Acetylcholine Receptor Subunit
20%
Risk of Death
20%
Gene Drug
20%
Adverse Prognosis
20%
Biochemistry, Genetics and Molecular Biology
CHRNB4
100%
Genomics
100%
Smoking
60%
Gene Expression Profiling
20%
Cancer Cell
20%
Cell Death
20%
Cell Migration
20%
Gene Mutation
20%
RNA Sequencing
20%
Angiogenesis
20%
Acetylcholine Receptor
20%
Genome Editing
20%
Varenicline
20%
Drug Inhibition
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Head and Neck Squamous Cell Carcinoma
100%
Head and Neck Cancer
100%
Recurrent Disease
25%
Malignant Neoplasm
25%
Distant Metastasis
25%
Cholinergic Receptor
25%
Varenicline
25%
Receptor Subunit
25%